688739 Stock Overview
A biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Liaoning Chengda Biotechnology Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥25.98 |
| 52 Week High | CN¥35.24 |
| 52 Week Low | CN¥24.61 |
| Beta | 0.63 |
| 1 Month Change | -8.81% |
| 3 Month Change | -9.57% |
| 1 Year Change | -20.06% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -67.53% |
Recent News & Updates
Some May Be Optimistic About Liaoning Chengda BiotechnologyLtd's (SHSE:688739) Earnings
Apr 29
Liaoning Chengda Biotechnology Co.,Ltd.'s (SHSE:688739) Price Is Right But Growth Is Lacking
Apr 24Shareholder Returns
| 688739 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 0.5% | -2.1% | 0.6% |
| 1Y | -20.1% | -19.7% | -15.5% |
Return vs Industry: 688739 matched the CN Biotechs industry which returned -19.7% over the past year.
Return vs Market: 688739 underperformed the CN Market which returned -15.5% over the past year.
Price Volatility
| 688739 volatility | |
|---|---|
| 688739 Average Weekly Movement | 3.0% |
| Biotechs Industry Average Movement | 6.1% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.1% |
| 10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 688739 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688739's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 1,732 | Yu Mao | www.cdbio.cn |
Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China. It offers Chengda Suda human rabies and Chengda Libao Human Type B inactivated encephalitis vaccines.
Liaoning Chengda Biotechnology Co.,Ltd. Fundamentals Summary
| 688739 fundamental statistics | |
|---|---|
| Market cap | CN¥10.84b |
| Earnings (TTM) | CN¥420.34m |
| Revenue (TTM) | CN¥1.76b |
25.5x
P/E Ratio6.1x
P/S RatioIs 688739 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688739 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.76b |
| Cost of Revenue | CN¥353.23m |
| Gross Profit | CN¥1.41b |
| Other Expenses | CN¥987.72m |
| Earnings | CN¥420.34m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.02 |
| Gross Margin | 79.95% |
| Net Profit Margin | 23.87% |
| Debt/Equity Ratio | 0% |
How did 688739 perform over the long term?
See historical performance and comparisonDividends
3.1%
Current Dividend Yield79%
Payout RatioDoes 688739 pay a reliable dividends?
See 688739 dividend history and benchmarks| Liaoning Chengda BiotechnologyLtd dividend dates | |
|---|---|
| Ex Dividend Date | Jun 20 2024 |
| Dividend Pay Date | Jun 20 2024 |
| Days until Ex dividend | 0 days |
| Days until Dividend pay date | 0 days |
Does 688739 pay a reliable dividends?
See 688739 dividend history and benchmarks